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Interpretation — Patient and THA procedure charac-
teristics as well as revision rates evinced some differences 
between the Netherlands and the Nordic countries. The Neth-
erlands compared best with Denmark in terms of patient and 
procedure characteristics, but resembled Sweden more in 
terms of short-term revision risk. Combining data from reg-
istries like LROI and the NARA collaboration is feasible and 
might possibly enable tracking of potential outlier implants.
Arthroplasty registries are used to evaluate patient, procedure, 
prosthesis, and hospital characteristics associated with revi-
sion surgery as well as to improve quality of care (Herberts 
and Malchau 2000, Graves 2010). Comparison of national 
arthroplasty registries is important to improve our understand-
ing of national differences and similarities. Furthermore, com-
bining data from arthroplasty registries from several countries 
is needed in order to increase numbers to create the possibility 
of detecting inferior implants as early as possible.
The Nordic Arthroplasty Register Association (NARA) 
was established in 2007 by representatives from arthroplasty 
registries in Sweden, Norway, and Denmark to improve 
the quality of total hip and total knee arthroplasty through 
a registries-based research collaboration. Finland joined the 
association in 2010. To date, NARA is the most developed 
multinational arthroplasty database worldwide (Mäkelä et al. 
2019). The comparison of national demographics and results 
was one of the main initial aims of the NARA collaboration. 
Background and purpose — Collaborations between 
arthroplasty registries are important in order to create the 
possibility of detecting inferior implants early and improve 
our understanding of differences between nations in terms of 
indications and outcomes. In this registry study we compared 
patient and procedure characteristics, and revision rates in 
the Nordic Arthroplasty Register Association (NARA) data-
base and the Dutch Arthroplasty Register (LROI).
Patients and methods — All total hip arthroplasties 
(THAs) performed in 2010–2016 were included from the 
LROI (n = 184,862) and the NARA database (n = 290,823), 
which contains data from Denmark, Norway, Sweden, and 
Finland. Descriptive statistics and Kaplan–Meier survival 
analyses based on all reasons for revision and stratified by 
fixation were performed and compared between countries.
Results — In the Netherlands, the proportion of patients 
aged < 55 years (9%) and male patients (34%) was lower than 
in Nordic countries (< 55 years 11–13%; males 35–43%); 
the proportion of osteoarthritis (OA) (87%) was higher com-
pared with Sweden (81%), Norway (77%), and Denmark 
(81%) but comparable to Finland (86%). Uncemented fixa-
tion was used in 62% of patients in the Netherlands, in 70% 
of patients in Denmark and Finland, and in 28% and 19% 
in Norway and Sweden, respectively. The 5-year revision 
rate for THAs for OA was lower in Sweden (2.3%, 95% CI 
2.1–2.5) than in the Netherlands (3.0%, CI 2.9–3.1), Norway 
(3.8%, CI 3.6–4.0), Denmark (4.6%, CI 4.4–4.8), and Fin-
land (4.4%, CI 4.3–4.5). Revision rates in Denmark, Norway, 
and Finland were higher for all fixation groups.
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Therefore, the NARA database contains only parameters that 
are included in all the individual registries (Havelin et al. 
2011).
The first NARA publication in 2009 described the results 
of 280,201 total hip arthroplasties (THAs) performed in 
1995–2006 in Sweden, Norway, and Denmark (Havelin et al. 
2009). This research was updated in 2014 by Mäkelä et al. 
using NARA data from 1995–2011 including Finland (Mäkelä 
et al. 2014). Substantial differences were found in the patient 
populations receiving a THA in the Nordic countries and in 
the procedure characteristics such as surgical approach and 
fixation (Mäkelä et al. 2014). Furthermore, substantial differ-
ences in 10-year survival rates were found between the Nordic 
countries (Havelin et al. 2009). The Dutch Arthroplasty Reg-
ister (LROI) contains data on THAs since 2007. We initiated 
this study to compare patient and treatment characteristics as 




The NARA database consists of pooled data from the national 
hip arthroplasty registries of Denmark, Norway, Finland, 
and Sweden. Each register has validation routines based on 
national patient registries. A minimal NARA dataset was cre-
ated that contains data that all registries could deliver, where 
personal identification numbers are deleted. The data were 
treated with full confidentiality, and identification of individ-
ual patients was not possible as a result of the anonymization 
of the NARA dataset (Havelin et al. 2009, 2011).
The degree of coverage and completeness of the Nordic reg-
istries is documented to be higher than 95% (DHAR, FAR, 
NAR, SHAR n.d.). Selection and transformation of the respec-
tive datasets and de-identification of the patients, including 
deletion of the national personal identity numbers, was per-
formed within each national registry. Anonymous data was then 
merged into a common research database. Ethical approval of 
the study was obtained through each national registry.
The LROI is the nationwide population-based register that 
includes information on arthroplasties in the Netherlands since 
2007. The LROI has coverage of 100% of Dutch hospitals and 
completeness of reporting of over 95% for primary THAs and 
88% for revision arthroplasties (LROI n.d., van Steenbergen et 
al. 2015). The LROI database contains information on patient, 
procedure, and prosthesis characteristics recorded by regis-
trars from each hospital. The LROI uses the opt-out system to 
require informed consent of patients. 
For the present study we included all primary THAs in the 
period 2010–2016 registered in the NARA (n = 290,823) and 
the LROI (n = 184,862). Bilateral procedures were included in 
the study, since they do not introduce significant dependency 
problems in register studies (Ranstam et al. 2011). Resurfac-
ing hip arthroplasties were excluded, though metal-on-metal 
total hip arthroplasties were included. Records with missing 
data were included.
Age was categorized into 4 groups (< 55, 55–64, 65–74, 
≥ 75). The categories for diagnosis differed slightly between 
NARA and the LROI. We harmonized LROI variables to the 
NARA minimal dataset of variables, with the main harmoni-
zation for childhood diseases being developmental dysplasia 
of the hip, Perthes disease, and slipped capital femoral epiphy-
sis and a combination of the latter two diagnoses in the NARA 
dataset compared with post-Perthes and dysplasia in the LROI 
(Table 1). Furthermore, surgical approach was divided into 
posterior and non-posterior.
Cause of revision was harmonized between the NARA and 
the LROI. In the LROI more than one cause of revision could 
be registered, which is not in line with the NARA where the 
main reason for revision is registered. Therefore, a hierarchi-
cal order of reasons for revision (similar to the order used on 
the Norwegian data: top to bottom; infection, aseptic loosen-
Table 1. Harmonization of LROI variables to the NARA minimal data-
set for diagnosis
NARA diagnosis LROI diagnosis
Primary osteoarthritis Osteoarthritis
Inflammatory arthritis Inflammatory arthritis
 Rheumatoid arthritis Rheumatoid arthritis
 Other inflammatory
 Ankylosing spondylitis 
Hip fracture Fracture (acute)
  Late posttraumatic
Pediatric hip disease Post-Perthes
 Developmental dysplasia of the hip Dysplasia
 Perthes disease
 Slipped capital femoral epiphysis
 Combination of slipped capital 
 femoral epiphysis and Perthes 
Idiopathic femoral head necrosis Osteonecrosis
Other Other
Table 2. Harmonization of LROI variables to the NARA minimal data-
set for cause of revision
NARA cause of revision  LROI cause of revision
Deep infection Infection
Aseptic loosening Loosening of acetabular component,  
  no infection
  Loosening of femoral component, 
  no infection
Periprosthetic fracture Periprosthetic fracture
Dislocation Dislocation
Pain only (not available)
Others Other
  Girdlestone situation
  Peri-articular ossification
  Inlay wear
  Symptomatic metal-on-metal bearing
Unknown No cause of revision registered for
  revision procedure
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ing, periprosthetic fracture, dislocation, other, missing) was 
used for the LROI data. Loosening of the acetabular and 
femoral component without infection as available in the LROI 
were combined as aseptic loosening (Table 2). In the LROI 
for 211 records (11%) more than one reason for revision was 
registered within 1 year of follow-up and 296 (8%) within the 
entire study period. The study is reported according to the 
STROBE guidelines.
Statistics
Descriptive statistics of patient and procedure characteristics 
as well as THA incidence per year based on the population per 
country was calculated, according to country. Survival time 
was calculated as the time from primary procedure to first all-
cause, any component revision, death of the patient, or end 
of the follow-up (January 1, 2017). Median follow-up was 3 
years (interquartile range: 1.4–4.8 years). Kaplan–Meier sur-
vival analyses were performed to evaluate time to all-cause any 
component revision including 95% confidence intervals (CI) 
according to countries for OA THA patients. Stratified analy-
ses were performed according to fixation and sex. Reasons for 
revision within 1 year and within 5 years’ follow-up time were 
described per country. For the 95% CIs, we assumed that the 
number of observed cases followed a Poisson distribution.
Ethics, registration, funding and potential conflicts of 
interests
The dataset was processed in compliance with the regulations 
of the LROI and NARA governing research on registry data. 
No external funding was received. No competing interests 
were declared. 
Results
475,685 THAs were included in the NARA and LROI data-
bases in the study period, with 39% of procedures from the 
Netherlands, 24% from Sweden, and around 12% each from 
Denmark, Norway, and Finland (Table 3). The volume of pri-
mary THAs increased each year in all 5 countries during the 
study period. The 2016 incidence rates of new THAs were 
around 170–175 per 100,000 inhabitants in NARA countries, 
and 150 in the Netherlands (Table 3).
Patient characteristics
In the Netherlands, the proportion of patients aged < 55 years 
was 9%, which was lower than that in the Nordic countries; in 
Finland 13% of THA patients were aged < 55 years. The pro-
portion of patients aged ≥ 75 years was comparable between the 
Netherlands, Denmark, and Sweden with 31–32% each, while 
this proportion was lower in Finland and Norway (28–29%). 
The proportion of male patients was lowest in the Netherlands 
at 34% compared with any of the Nordic countries (35–43%). 
The proportion of THAs due to primary osteoarthritis (OA) 
was higher in the Netherlands (87%) than in Sweden, Norway, 
and Denmark, but comparable to Finland. The proportion of 
hip fractures was lower in the Netherlands compared with 
Denmark, Sweden, and to a lesser extent Norway. The pro-
portion of inflammatory arthritis differed between the coun-
tries, from 0.9% in the Netherlands up to 2.5% in Finland. In 
Denmark and Sweden hip fracture as diagnosis for THA was 
almost twice as frequent as in the Netherlands and almost 3 
times more frequent than in Finland (Table 4).
Procedure characteristics
Uncemented fixation of both components was used in 62% 
of patients in the Netherlands, in 70% of patients in Denmark 
and Finland, and in 28% and 19% in Norway and Sweden, 
respectively.
In the Netherlands, a posterior hip approach was used in 
61% of the THA procedures, which was in between Sweden 
Table 3. Primary total hip arthroplasty volume per country
     The Nether-
 Denmark Norway Sweden Finland lands
Annual primary THA volume
 2010   8,478   7,254   15,730   7,153   23,206
 2011   8566   7,318   15,784   7,538   23,859
 2012   8,536   7,822   15,958   7,895   25,299
 2013   8,774   8,087   16,278   8,172   26,038
 2014   9,174   8,112   16,528   8,348   28,073
 2015   9,516   8,437   16,630   9,015   28,795
 2016   9,913   8,873   17,261   9,673   29,592
 Total 62,957 55,903 114,169 57,794 184,862
 % of total 13 12   24 12   39
Population 2016 (million) and THA incidence 2016 (per 105)
 Population   5.7   5.2 10.0   5.5   17.0
 Incidence 174 170 173 176   150
 
Table 4. Characteristics of the total hip arthroplasty patients and 
procedures registered in the NARA and LROI database, 2010–2016 
(n = 475,685). Values are percentages unless otherwise specified
      The
  Den- Nor-  Fin- Nether-
Factor mark way Sweden land lands
No. of THAs 62,957 55,903 114,169 57,794 184,862
Male sex 43 35 42 43 34
Age
  < 55 12 11 11 13 9.0
  55–64 19 23 20 23 22
  65–74 38 37 38 36 38
  ≥ 75 31 29 31 28 32
Diagnosis
 Primary osteoarthritis 81 77 81 86 87
 Inflammatory arthritis 1.1 2.1 1.1 2.5 0.9
 Hip fracture 11 8.2 11 3.9 6.2
 Pediatric hip diseases 3.3 8.8 1.9 0.9 2.3
 Idiopathic head necrosis 2.3 2.2 2.2 1.8 2.9
 Others 0.9 1.3 3.0 4.8 0.7
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Table 5. Procedure characteristics of the total hip arthroplasty 
patients and procedures registered in the NARA and LROI database, 
2010–2016 (n = 475,685). Values are percentages unless otherwise 
specified
      The
  Den- Nor-  Fin- Nether-
Factor mark way Sweden land lands
No. of THAs 62,957 55,903 114,169 57,794 184,862
Fixation
 Cemented 12 31 66 11 28
 Uncemented 70 28 19 71 62
 Hybrid 16 3.0 2.8 15 4.6
 Reverse hybrid 0.9 37 13 1.7 4.7
 Unknown, uncertain 0.6 1.4 0.0 1.8 0.6
Posterior approach 96 39 52 67 a            61
a For Finland approach is available since 2014, proportion shown is 
for 2014–2016.
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Figure 1. Cumulative revision proportion (%) of 
THAs for OA according to country, all fixation 
methods.
(52%) and Finland (67%), but lower than in Denmark (96%) 
and higher compared with Norway (40%) (Table 5).
Figure 2. Cumulative revision proportion (%) of cemented THAs (a), uncemented THAs (b), hybrid 






In THAs for primary OA the 1-, 3-, 
and 5-year overall revision rates were 
lowest in Sweden. The Netherlands 
had a higher revision rate (5-year revi-
sion rate: 3.0%, CI 2.9–3.1) compared 
with Sweden (2.3%, CI 2.1–2.5), but 
a lower revision rate compared with 
Denmark (4.6%, CI 4.4–4.8), Norway 
(3.8%, CI 3.6–4.0), and Finland (4.4%, 
CI 4.3–4.5) (Table 6, Figure 1). Strati-
fied analyses showed lower revision 
rates for cemented THAs in Sweden 
and the Netherlands compared with 
Denmark, Norway, and Finland. Unce-
mented THAs had lower 3- and 5-year 
revision rates in the Netherlands and 
Sweden than in Norway, Denmark, 
and Finland. Hybrid (femur cemented) 
and reverse hybrid (cup cemented) 
THAs had lowest short-term revision 
rates in Sweden (Table 6, Figure 2). 
However, the number of cases with 
reverse hybrid THAs was small in 
Finland and too small in Denmark for 
meaningful analyses. Therefore the 
reverse hybrid cases from Denmark 
were excluded. Stratified analyses by 
sex showed comparable results for 
short-term overall revision rates exam-
ining differences between countries. 
Short-term overall revision rates were 
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Reason for revision
The most frequent reason for revision in 
the first year after primary THA differed 
between countries; dislocation was the 
most frequently registered reason for revi-
sion within the first year for Denmark and 
the Netherlands. For Norway, Sweden, and 
Finland deep infection was the most fre-
quent reason for revision (Table 7). After 
up to 5 years of follow-up, dislocation and 
infection were the most common reasons 
for revision in the Nordic countries, while 
aseptic loosening was the most frequently 
registered reason for revision within 5 
years of follow-up in the Netherlands. 
Discussion
This study provides the first comparison 
between the NARA countries (Denmark, 
Finland, Norway, and Sweden) and the 
Netherlands for primary THA procedures. 
Combining data from different national 
arthroplasty registries like NARA and 
LROI is possible for patient and proce-
dure characteristics as well as for revision 
rates and reasons for revision. When com-
bining datasets some requirements are 
necessary such as harmonizing categories 
of diagnosis and reasons for revision.
Table 6. Kaplan–Meier revision rates (%) with 95% confidence intervals at 1, 3, and 5 
years after primary total hip arthroplasties for osteoarthritis
Factor THAs Revisions 1–year 3–year 5–year
 Country  (n)  (n) revision rate revision rate revision rate
All THAs 
 Denmark 50,777 1,910 2.6 (2.4–2.8) 3.8 (3.6–4.0) 4.6 (4.4–4.8)
 Norway 42,941 1,364 2.3 (2.1–2.5) 3.2 (3.0–3.4) 3.8 (3.6–4.0)
 Sweden 92,069 1,722 1.2 (1.2–1.2) 1.8 (1.8–1.8) 2.3 (2.1–2.5)
 Finland 48,597 1,672 2.2 (2.0–2.4) 3.3 (3.1–3.5) 4.4 (4.3–4.5)
 The Netherlands 159,386 3,791 1.4 (1.4–1.5) 2.4 (2.3–2.5) 3.0 (2.9–3.1)
Cemented THA 
 Denmark 5,716 202 2.2 (2.0–2.4) 3.5 (3.2–3.8) 4.2 (3.9–4.5)
 Norway 13,491 423 2.1 (2.0–2.2) 3.1 (2.9–3.3) 3.8 (3.6–4.0)
 Sweden 59,568 945 1.0 (1.0–1.0) 1.5 (1.4–1.6) 2.0 (1.9–2.1)
 Finland 5,029 145 1.6 (1.4–1.8) 2.5 (2.3–2.7) 3.4 (3.1–3.7)
 The Netherlands 43,095 765 1.0 (0.9–1.1) 1.8 (1.6–1.9) 2.2 (2.1–2.4)
Uncemented THA 
 Denmark 37,330 1,478 2.8 (2.7–2.9) 4.0 (3.9–4.1) 4.9 (4.8–5.0)
 Norway 11,610 415 2.7 (2.5–2.9) 3.8 (3.6–4.0) 4.3 (4.1–4.5)
 Sweden 17,558 470 1.8 (1.7–1.9) 2.8 (2.7–2.9) 3.5 (3.3–3.7)
 Finland 34,976 1,323 2.3 (2.2–2.4) 3.6 (3.5–3.7) 4.7 (4.6–4.8)
 The Netherlands 101,249 2,608 1.5 (1.4–1.6) 2.6 (2.5–2.7) 3.3 (3.2–3.4)
Hybrid THA (femur cemented) 
 Denmark 7,288 201 1.8 (1.5–2.1) 2.8 (2.4–3.3) 3.5 (2.9–4.0)
 Norway 1148 28 2.2 (1.3–3.1) 2.9 (1.7–4.1) 3.8 (1.6–6.0)
 Sweden 2395 34 1.1 (0.7–1.6) 1.5 (1.0–2.1) 1.9 (1.1–2.7)
 Finland 7198 165 1.9 (1.6–2.3) 2.5 (2.1–2.9) 3.1 (2.5–3.7)
 The Netherlands 7,242 171 1.4 (1.2–1.7) 2.5 (2.1–2.9) 3.2 (2.7–3.7)
Reverse hybrid THA (cup cemented) 
 Denmark 285 21 n.a. n.a. n.a.
 Norway 16,329 485 2.1 (1.9–2.3) 3.0 (2.7–3.3) 3.5 (3.2–3.9)
 Sweden 12,546 273 1.3 (1.1–1.5) 2.1 (1.9–2.4) 2.6 (2.2–2.9)
 Finland 771 22 1.7 (0.8–2.7) 2.5 (1.4–3.7) 3.1 (1.8–4.5)
 The Netherlands 6,992 225 1.9 (1.6–2.3) 3.4 (3.0–3.9) 4.0 (3.5–4.6)
n.a. = not available, numbers are too small.
      The
  Den- Nor-  Fin- Nether-
Factor mark way Sweden land lands
Revisions within 1 year (n = 401,878) a 
 THAs 42,628 36,149 78,073 40,552 133,985
 Revisions 1,420 1,087 1,338 1,145 1,935
 Cause of revision
      Dislocation 0.77 0.36 0.29 0.48 0.40
      Deep infection 0.71 1.08 0.77 0.54 0.27
      Aseptic loosening 0.25 0.26 0.10 0.19 0.34
      Periprosthetic fracture 0.61 0.21 0.17 0.41 0.18
      Pain only 0.06 0.03 0.01 0.01 n.a.  
     Others 0.26 0.21 0.04 0.51 0.18
      Unknown 0.02 0.15 0.00 0.21 0.09
a In 2010–2015 to assure at least 1-year follow-up for all records.  
      The
  Den- Nor-  Fin- Nether-
Factor mark way Sweden land lands
Revisions up to the 5-year follow-up (n = 475,685)
 THAs (n) 50,777 42,941 92,069 48,597 159,386
 Revisions 1,910 1,364 1,722 1,672 3,854
 Cause of revision 
      Dislocation 0.98 0.55 0.36 0.64 0.60
      Deep infection 0.86 1.18 0.87 0.64 0.44
      Aseptic loosening 0.61 0.56 0.32 0.41 0.66
      Periprosthetic fracture 0.73 0.26 0.21 0.50 0.23
      Pain only 0.18 0.15 0.03 0.06 n.a.
      Others 0.36 0.29 0.08 0.95 0.40
      Unknown 0.03 0.18 0.00 0.25 0.10
n.a. = not available. 
Table 7. Reasons for revision (%) within 1 year and up to 5-year follow-up of total hip arthroplasties for osteoarthritis registered in the NARA 
and LROI database
somewhat higher for males compared with females in all 
countries (data not shown). Analyses of the whole study 
population including cases with non-OA diagnoses gave the 
same results (data not shown).
Patient and procedure characteristics
Our findings concerning patient and procedure characteristics 
of the NARA countries are in line with previously reported 
results. However, the proportion of male patients is somewhat 
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higher in all NARA countries, especially in Norway compared 
with earlier NARA results (Mäkelä et al. 2014). Dutch patients 
who received a THA were generally somewhat older than THA 
patients in NARA countries, with Finland having a known 
younger THA population (Mäkelä et al. 2014). Furthermore, 
the proportion of OA as the diagnosis for primary THA was 
higher in the Netherlands compared with the Nordic countries, 
whereas the proportion of hip fractures was lower in the Neth-
erlands compared with Denmark, Norway, and Sweden. This 
might be the result of the varying indications for use of THA for 
fracture patients in the Nordic countries and the Netherlands. 
The incidence of THA is in line with reported international 
THA incidence rates (Merx et al. 2003, Paxton et al. 2019), but 
seems to be somewhat lower in the Netherlands compared with 
the Nordic countries. This may reflect differences in demogra-
phy, prevalence of various hip diseases, indications for surgical 
treatment, and/or healthcare policy between countries. 
Apart from the differences in patient population, procedure 
characteristics also differed between the Netherlands and the 
Nordic countries. The Netherlands was most comparable to 
Denmark and Finland concerning THA fixation technique. 
These countries had a high proportion of uncemented fixa-
tion, while Norway and Sweden had a low proportion of unce-
mented fixation. Good results of cemented THA and inferior 
results of some uncemented THAs in the Swedish and Norwe-
gian registries have encouraged the continued use of cemented 
THA in these countries (Havelin et al. 2009). However, unce-
mented fixation as well as reverse hybrid fixation increased in 
both Norway and Sweden during the study period. 
Revision
There were differences in short-term revision rates between 
NARA countries and the Netherlands for all evaluated hip 
stem and acetabular fixation group combinations. Although 
differences were small, revision risk at short-term follow-up 
was lowest in Sweden for cemented THAs. The Swedish Hip 
Arthroplasty Register (SHAR) has provided feedback and 
advice to the orthopedic surgeons for over 40 years (SHAR 
n.d.). However, Dutch results showed comparable low short-
term revision rates as well. The higher short-term revision 
rates for THAs in Denmark and Finland might be explained by 
more dislocations due to the posterior approach (Zijlstra et al. 
2017), which is frequently used in these countries. However, 
the posterior approach has been shown to give better patient-
reported outcomes (Amlie et al. 2014, Rosenlund et al. 2017). 
Results of large femoral head metal-on-metal THAs have 
been poor (Seppanen et al. 2018), which may be an impor-
tant factor in the explanation for the higher revision rates in 
uncemented THAs in Denmark and Finland where the propor-
tion of these THAs was high. However, in the Netherlands 
these large femoral head metal-on metal THAs were also used 
in substantial numbers (LROI n.d.). Unfortunately we were 
not able to exclude these big head metal-on-metal cases from 
our analyses because we did not include femoral head size 
or articulating materials in this data set. Furthermore, patient 
characteristics are likely to play a role in the revision rates 
of THAs, with Finland having a younger patient population 
that might partly explain their higher short-term revision rate 
(FAR, LROI n.d.).
Reverse hybrid and hybrid THAs had the lowest short-term 
revision rates in Sweden, being lower than in the Netherlands. It 
has been stated previously based on NARA data, however, that 
reverse hybrid THA has a higher revision rate than cemented 
THA, mainly due to periprosthetic fractures (Wangen et al. 
2017). The number of reverse THAs in the Nordic countries 
has decreased in recent years, after the period of the current 
study (2010–2016).
Cause of revision differed between countries, with dislocation 
being the most frequent reason for revision in the Netherlands 
and Denmark. This is probably related to a higher proportion of 
the THAs done with a posterior approach. Infection represents 
a major share of the short-term revisions, which might substan-
tially influence the short-term revision rate. However, infection 
as a reason for revision should be considered carefully, since the 
capture rate in arthroplasty registries is known to be suboptimal, 
with up to 40% of revision procedures with proven infections 
missing (Gundtoft et al. 2015). This might be different between 
countries, which most likely biases the results. Validity of revi-
sion for infection largely depends on the possibility to validate 
registry data with other datasets from, e.g., microbiology. Cur-
rently, a study is being performed in the Netherlands to exam-
ine the proportion of revisions for infections not registered in 
the LROI, which is expected to be comparable to the study by 
Gundtoft et al. The proportion of unknown reasons for revision 
differed substantially between countries, which also might bias 
the short-term results. 
Strengths and weaknesses
The strength of this study is the large population-based reg-
istry dataset from 5 countries with high-quality data and 
minimal loss to follow-up from each national register. Com-
pleteness of data in the included registries is documented to 
be higher than 95% (DHAR, FAR, LROI, NAR, SHAR n.d.). 
Furthermore, registries provide real-world data with high gen-
eralizability and external validity. This gives us the opportu-
nity to describe trends and differences between countries. On 
the other hand, our registry data are observational and can be 
subject to bias that we cannot account for, i.e., selection bias 
and confounding by indication by surgeon. Therefore, causal-
ity cannot be inferred. Data used for this project is limited by 
being common to all 5 registries, and hence we lack informa-
tion on some factors that affect the outcomes. In this first study 
comparing LROI and NARA data we did not merge the data-
sets, hampering the possibility to perform adjusted analyses.
In this study we examined and compared NARA and LROI 
data from a relatively recent period, resulting in a limited fol-
low-up of THA procedures with a maximum of 7 years. Fur-
thermore, we did not include femoral head size or type of artic-
ulation, which are known factors influencing revision rates. 
Moreover, we were not able to exclude metal-on-metal THAs, 
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which have a known high revision rate (Smith et al. 2012).
In addition, we evaluated overall revision, which contains 
a variety of revision procedures ranging from small revision 
procedures like femoral head exchange to major revision pro-
cedures such as complete exchange or extraction of all compo-
nents. The type of revision procedure performed might differ 
between countries, resulting in differences in revision rates. 
Moreover, the threshold for performing revision procedures 
may vary between countries, which influences revision rates.
Demographics of the Nordic countries and the Netherlands are 
comparable, although there are substantial differences in travel 
distance to the nearest (revision) hospital between the Nether-
lands and, e.g., the rural areas of the Nordic countries. Further-
more, the Nordic countries as well as the Netherlands have a 
solid healthcare system. However, while the health expenditure 
of the Nordic countries is mainly paid by the government, the 
health expenditure of the Netherlands is mainly covered by 
compulsory health insurance (OECD n.d., OECD 2019).
Conclusion
Patient and THA procedure characteristics as well as revision 
rates evinced some differences between the Netherlands and 
the Nordic countries, although the magnitude of differences 
was small. The Netherlands seemed to compare best to Den-
mark in terms of patient and procedure characteristics, but was 
most comparable to Sweden in terms of short-term revision 
risk for both cemented and uncemented THAs. The observed 
absolute differences in revision risk were small and might not 
be clinically relevant, since they most likely are a reflection 
of variations in demographics, patient selection, procedure 
characteristics, or indications for revision. However, most of 
these factors cannot be studied based on the common data 
available. Combining data from registries like LROI and those 
included in the NARA collaboration is feasible. This might 
possibly enable tracking of potential outlier implants, specific 
patient groups, or events with a relatively low occurrence. Fur-
ther research is warranted to merge datasets and look at more 
details concerning THA, creating the opportunity to perform 
patient-, procedure-, and prosthesis-adjusted analyses. 
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